China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange China Medical System Holdings Ltd. Jun 25, 2025 19:00 JST Read More
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis Hua Medicine Jun 23, 2025 12:05 HKT/SGT Read More
CanSinoBIO Launches Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health CanSino Biologics Inc Jun 20, 2025 18:06 HKT/SGT Read More
NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment NEC Corporation Jun 18, 2025 12:40 HKT/SGT Read More
Jacobson Pharma Announces FY2025 Annual Results Jacobson Pharma Corporation Limited Jun 13, 2025 19:16 HKT/SGT Read More
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050 NEC Corporation Jun 02, 2025 16:56 HKT/SGT Read More
Eisai to Launch "Pariet S," the First Proton Pump Inhibitor RX-to-OTC in Japan Eisai Jun 02, 2025 16:46 HKT/SGT Read More
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China Eisai May 28, 2025 16:45 HKT/SGT Read More
JCB Collaborates with Noage International to Expand Advanced Medical Tourism Program in Japan for Affluent Indonesians JCB May 27, 2025 09:00 HKT/SGT Read More
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 Eisai May 21, 2025 14:00 HKT/SGT Read More
Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro Eisai May 16, 2025 16:21 HKT/SGT Read More
Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China Everest Medicines Limited May 07, 2025 18:06 HKT/SGT Read More
Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star Eisai Apr 30, 2025 13:17 HKT/SGT Read More
A Decade of Olympus India's Commitment to Community Welfare Olympus Apr 22, 2025 12:00 HKT/SGT Read More
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union Eisai Apr 18, 2025 15:52 HKT/SGT Read More
エーザイとバイオジェン、「レケンビ」（レカネマブ）が欧州連合（EU）において早期アルツハイマー病の進行を抑制する初めての治療剤として承認を取得 Eisai Apr 16, 2025 11:30 JST Read More
